Sequelae of Sars-CoV-2 Infections

Recruiting Observational Study
Lung Diseases Cardiac Disease Inflammatory Reaction
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
120 (estimated)
Sponsor
University of Giessen · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
By the end of 2019 a new coronavirus, named SARS-CoV-2, was discovered in patients with pneumonia in Wuhan, China. In the following weeks and months the virus spread globally, having a tremendous impact on global health and economy. To date, no vaccine or therapy is available. Severe courses of the infection not only affect the lungs, but also other organs like the heart, kidney, or liver. The lac…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * hospitalization due to Sars-CoV-2 infection Exclusion Criteria: * under 18 years of age
Contacts

Ulrich Matt, MD, PhD

0049-(0)641-985-58773

ulrich.matt@innere.med.uni-giessen.de

CONTACT

Khodr Tello, MD

khodr.tello@innere.med.uni-giessen.de

CONTACT